reference/30504296

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30504296

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	0014-4886
pageRange	113863-
publicationName	Experimental Neurology
startingPage	113863
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_57a0fb736775e57072621b0bf917dfcb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8141a11968a262e2a8e1a5e2d787744b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5e5a0fb54b9b21e4c34cbb7f17fd07eb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb8eb1d03a338f30270ca8d09a6f769a
bibliographicCitation	Yeh TH, Liu HF, Chiu CC, Cheng ML, Huang GJ, Huang YC, Liu YC, Huang YZ, Lu CS, Chen YC, Chen HY, Cheng YC. PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia-parkinsonism type 14 and can be relieved by DHA treatment in animal models. Exp Neurol. 2021 Dec;346():113863. doi: 10.1016/j.expneurol.2021.113863. PMID: 34520727.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b96ce02220e987cfa19b76d7ec059db7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4cf550e428647ad9a79b2fd83521bd1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9dfef5f787078fe6e7946c36ff018da http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d22f982ee14425f96cf178947400d3f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c0fdde75f3484e7383be0caefe900b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7efa860c281f90cf7d1cbed76d8faf2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9bbf30bfad17b0a1aab06946dd49bf4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee67d8eb265687c89793c861f0278e9d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d740fa4d9ba8326931ee32f47b9a81b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7d8a84147919bb8d3ca3200f089e314 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1827-8049 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bfb74c3536fa0651dda454f95b0a1d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cdf1976c06533674c9b3a2d371efa3a
date	202112
identifier	https://doi.org/10.1016/j.expneurol.2021.113863 https://pubmed.ncbi.nlm.nih.gov/34520727
isPartOf	https://portal.issn.org/resource/ISSN/0014-4886 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3660
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia–parkinsonism type 14 and can be relieved by DHA treatment in animal models
discusses	http://id.nlm.nih.gov/mesh/M0505548 http://id.nlm.nih.gov/mesh/M0505774 http://id.nlm.nih.gov/mesh/M0006701 http://id.nlm.nih.gov/mesh/M0012434
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009154Q000235 http://id.nlm.nih.gov/mesh/D010641 http://id.nlm.nih.gov/mesh/D020734Q000235 http://id.nlm.nih.gov/mesh/D004281Q000627 http://id.nlm.nih.gov/mesh/D054522Q000235 http://id.nlm.nih.gov/mesh/D020734Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007980Q000494 http://id.nlm.nih.gov/mesh/D015027 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D007980Q000627 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004281Q000494 http://id.nlm.nih.gov/mesh/D008822 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445580 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7524 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6516 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10611 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c1eaf4dbb45b2aa77ed0ccc9263f6fca http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10395 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8805

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID53357 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID406370

Total number of triples: 62.